Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis

Published:2017-08 Issue:10096 Volume:390 Page:747-759
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Jinatongthai Peerawat,Kongwatcharapong Junporn,Foo Chee Yoong,Phrommintikul Arintaya,Nathisuwan Surakit,Thakkinstian Ammarin,Reid Christopher M,Chaiyakunapruk Nathorn

Publisher

Elsevier BV

Subject

General Medicine

Reference79 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013;Lancet,2015

2. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara;J Am Coll Cardiol,2013

3. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation;Steg;Eur Heart J,2012

4. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour;Boersma;Lancet,1996

5. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial;Weaver;JAMA,1993

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation and in vitro evaluation of tissue plasminogen activator-loaded nanoliposomes with anticoagulant coating;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-11

2. Adverse events of tissue plasminogen activators in acute myocardial infarction patients: a real-world and pharmacovigilance database analysis;BMC Cardiovascular Disorders;2024-08-23

3. Cardiovascular disease and thrombosis: Intersections with the immune system, inflammation, and the coagulation system;Annales Pharmaceutiques Françaises;2024-08

4. Reteplase: A promising alternative in acute ischemic stroke management;Neurosurgical Review;2024-07-31

5. Reteplase versus Alteplase for Acute Ischemic Stroke;New England Journal of Medicine;2024-06-27